Form 4: Director Uri Geiger Increases Stake in NeuroPace

Director Uri Geiger acquired 2,890 shares of common stock and 5,368 stock options in NeuroPace, Inc. as part of annual compensation.

Summary

• Director Uri Geiger was granted 2,890 shares of common stock on June 5, 2026.
• The director also received a stock option grant for 5,368 shares with an exercise price of $15.74.
• The shares and options vest in twelve equal monthly installments, contingent on continuous service.
• Following the transaction, the director holds 17,748 shares directly and maintains indirect control over 4,432,948 shares via Accelmed Partners II LP.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• Director demonstrates continued commitment to the company through equity-based compensation.
• Alignment of director interests with shareholders through long-term vesting schedules.

Negatives

• None identified; this is a standard compensatory filing.

Risks

• Vesting is subject to the reporting person's continuous service to the company.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a disclosure of director equity compensation.

Industry Context

StockSavvy.ai notes that routine equity grants to board members are standard practice in the medical device sector to ensure long-term alignment between leadership and shareholders.

Comparison to Industry Standards

• The grant structure follows standard industry practices for non-employee director compensation.
• Vesting schedules of 12 months are consistent with typical retention strategies for board members in the healthcare technology space.

Related Party Transactions

• The director maintains indirect beneficial ownership of 4,432,948 shares held by Accelmed Partners II LP.

Stakeholder Impact

• Minimal impact on shareholders as this represents standard director compensation.

Next Steps

• Vesting of shares and options in twelve equal monthly installments.

Key Dates

Keywords

NeuroPace, NPCE, Form 4, Insider Trading, Director Compensation, Equity Grant